Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures

NCT05292846 is registered in ClinicalTrials.gov with Hospital Universitario La Fe as lead sponsor.

NCT NCT05292846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures
Lead sponsor
Hospital Universitario La Fe
Phase
Phase 4
Overall status
Unknown status
Start date
January 20, 2022
Completion date
April 20, 2024
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, coronary artery disease, direct acting anticoagulant adverse reaction